AN INTERNATIONAL NETWORK OF HOSPITAL CENTRE OF CELL THERAPY EXCELLENCE BASED GMP MANUFACTURING ATMP PODs

aCGT Vector’s focus is Cellular Therapy, rapidly evolving as a therapeutic approach that brings tremendous hope to patients, their families and clinicians; for the treatment of rare diseases, most critically cancer. Less than 5% of patients suffering from rare diseases today have any therapeutic option available to them. 

Cell Therapy

aCGT Vector’s Cellular Therapy procedures will involve collecting patients‘ own immune cells and bringing them safely to its GMP facility inside the hospital for process engineering and potential exponential expansion in volume, to make these immune cells more strategically effective, before being administered back into the same patient.

AUTOLOGOUS CELLULAR THERAPY

The safest and most certain approach being taken today, where the patients’ own immune cells are removed, transformed and potentially expanded in volume using aCGT Vector’s modern closed-ex-vivo-system technology and state of the art GMP facility.

The modified immune cells are then re-infused back into the same patient to target and treat their own rate disease. This entirely avoids any and all risks of their own immune system identifying these incoming cells as foreign and rejecting them which could prove fatal to often immune system compromised patients.

Small text

EU-BASED CELL THERAPY BUSINESS

ATMP GMP-in-a-BOX in Cellular Therapy hospital centres of excellence.

GMP-in-a-POD

The Future of Cell Therapy is Modular Agile Digitised Interconnected GMP-in-a-POD

stay up to date

Read all about out current treatments, processes and upcoming events

CONTACT US

© aCGT Vector – All Rights Reserved

Adress

aCGT Vector DAC,

The Mill Enterprise Hub,

Newtown Link Road,

Greenhills, Drogheda,

Co. Louth, A92 CD3D,

Republic of Ireland,

Europe

Contact

+353 864667889

[email protected]